316 related articles for article (PubMed ID: 17786145)
1. Antiviral therapy: inhibition of Hepatitis C Virus expression by RNA interference directed against the NS5B region of the viral genome.
Trejo-Avila L; Elizondo-González R; Trujillo-Murillo Kdel C; Zapata-Benavides P; Rodríguez-Padilla C; Rivas-Estilla AM
Ann Hepatol; 2007; 6(3):174-80. PubMed ID: 17786145
[TBL] [Abstract][Full Text] [Related]
2. Suppression of hepatitis C virus replicon by RNA interference directed against the NS3 and NS5B regions of the viral genome.
Takigawa Y; Nagano-Fujii M; Deng L; Hidajat R; Tanaka M; Mizuta H; Hotta H
Microbiol Immunol; 2004; 48(8):591-8. PubMed ID: 15322339
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of hepatitis C virus translation and subgenomic replication by siRNAs directed against highly conserved HCV sequence and cellular HCV cofactors.
Korf M; Jarczak D; Beger C; Manns MP; Krüger M
J Hepatol; 2005 Aug; 43(2):225-34. PubMed ID: 15964661
[TBL] [Abstract][Full Text] [Related]
4. Post-transcriptional inhibition of hepatitis C virus replication through small interference RNA.
Ali Ashfaq U; Ansar M; Sarwar MT; Javed T; Rehman S; Riazuddin S
Virol J; 2011 Mar; 8():112. PubMed ID: 21388559
[TBL] [Abstract][Full Text] [Related]
5. siRNA-resistance in treated HCV replicon cells is correlated with the development of specific HCV mutations.
Konishi M; Wu CH; Kaito M; Hayashi K; Watanabe S; Adachi Y; Wu GY
J Viral Hepat; 2006 Nov; 13(11):756-61. PubMed ID: 17052275
[TBL] [Abstract][Full Text] [Related]
6. Tricistronic hepatitis C virus subgenomic replicon expressing double transgenes.
Cheng X; Gao XC; Wang JP; Yang XY; Wang Y; Li BS; Kang FB; Li HJ; Nan YM; Sun DX
World J Gastroenterol; 2014 Dec; 20(48):18284-95. PubMed ID: 25561795
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of subgenomic hepatitis C virus RNA in Huh-7 cells: ribavirin induces mutagenesis in HCV RNA.
Kanda T; Yokosuka O; Imazeki F; Tanaka M; Shino Y; Shimada H; Tomonaga T; Nomura F; Nagao K; Ochiai T; Saisho H
J Viral Hepat; 2004 Nov; 11(6):479-87. PubMed ID: 15500548
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of full length hepatitis C virus particles of 1a genotype through small interference RNA.
Ansar M; Ashfaq UA; Shahid I; Sarwar MT; Javed T; Rehman S; Hassan S; Riazuddin S
Virol J; 2011 May; 8():203. PubMed ID: 21535893
[TBL] [Abstract][Full Text] [Related]
9. Development of full-length cell-culture infectious clone and subgenomic replicon for a genotype 3a isolate of hepatitis C virus.
Chen M; Xu Y; Li N; Yin P; Zhou Q; Feng S; Wu T; Wei L; Wang H; Fu Y; Li YP
J Gen Virol; 2021 Dec; 102(12):. PubMed ID: 34949310
[TBL] [Abstract][Full Text] [Related]
10. Identification of a ribavirin-resistant NS5B mutation of hepatitis C virus during ribavirin monotherapy.
Young KC; Lindsay KL; Lee KJ; Liu WC; He JW; Milstein SL; Lai MM
Hepatology; 2003 Oct; 38(4):869-78. PubMed ID: 14512874
[TBL] [Abstract][Full Text] [Related]
11. Interference of HCV replication by cell penetrable human monoclonal scFv specific to NS5B polymerase.
Thueng-in K; Thanongsaksrikul J; Jittavisutthikul S; Seesuay W; Chulanetra M; Sakolvaree Y; Srimanote P; Chaicumpa W
MAbs; 2014; 6(5):1327-39. PubMed ID: 25517317
[TBL] [Abstract][Full Text] [Related]
12. Resistance analysis and characterization of NITD008 as an adenosine analog inhibitor against hepatitis C virus.
Qing J; Luo R; Wang Y; Nong J; Wu M; Shao Y; Tang R; Yu X; Yin Z; Sun Y
Antiviral Res; 2016 Feb; 126():43-54. PubMed ID: 26724382
[TBL] [Abstract][Full Text] [Related]
13. Selectable subgenomic and genome-length dicistronic RNAs derived from an infectious molecular clone of the HCV-N strain of hepatitis C virus replicate efficiently in cultured Huh7 cells.
Ikeda M; Yi M; Li K; Lemon SM
J Virol; 2002 Mar; 76(6):2997-3006. PubMed ID: 11861865
[TBL] [Abstract][Full Text] [Related]
14. Mutagenic effect of ribavirin on hepatitis C nonstructural 5B quasispecies in vitro and during antiviral therapy.
Hofmann WP; Polta A; Herrmann E; Mihm U; Kronenberger B; Sonntag T; Lohmann V; Schönberger B; Zeuzem S; Sarrazin C
Gastroenterology; 2007 Mar; 132(3):921-30. PubMed ID: 17383421
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of hepatitis C virus gene expression by small interfering RNAs using a tri-cistronic full-length viral replicon and a transient mouse model.
Kim M; Shin D; Kim SI; Park M
Virus Res; 2006 Dec; 122(1-2):1-10. PubMed ID: 16979254
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C virus replicons escape RNA interference induced by a short interfering RNA directed against the NS5b coding region.
Wilson JA; Richardson CD
J Virol; 2005 Jun; 79(11):7050-8. PubMed ID: 15890944
[TBL] [Abstract][Full Text] [Related]
17. Small interfering RNA effectively inhibits protein expression and negative strand RNA synthesis from a full-length hepatitis C virus clone.
Prabhu R; Vittal P; Yin Q; Flemington E; Garry R; Robichaux WH; Dash S
J Med Virol; 2005 Aug; 76(4):511-9. PubMed ID: 15977238
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of canonical siRNA and Dicer substrate RNA for inhibition of hepatitis C virus genome replication--a comparative study.
Carneiro B; Braga AC; Batista MN; Harris M; Rahal P
PLoS One; 2015; 10(2):e0117742. PubMed ID: 25705875
[TBL] [Abstract][Full Text] [Related]
19. Dominant negative effect of wild-type NS5A on NS5A-adapted subgenomic hepatitis C virus RNA replicon.
Graziani R; Paonessa G
J Gen Virol; 2004 Jul; 85(Pt 7):1867-1875. PubMed ID: 15218171
[TBL] [Abstract][Full Text] [Related]
20. Characterization of
Shahid I; Almalki WH; Ibrahim MM; Alghamdi SA; Mukhtar MH; Almalki SSR; Alkahtani SA; Alhaidari MS
Indian J Med Microbiol; 2018; 36(4):494-503. PubMed ID: 30880695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
